Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood samples sought to build immune cell lab tool

NCT ID NCT00571389

Recruiting now Knowledge-focused Sponsor: BioCytics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects blood samples from 1,500 adults, including cancer patients, healthy volunteers, and COVID-19 donors. Researchers aim to develop a device that can grow, select, and test immune cells (T cells) from the blood. The goal is to see if these cells can be trained to attack tumor cells in the lab, which could lead to better cancer treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help create a lab tool to grow and test immune cells, potentially pointing toward better personalized cancer treatments.
What could go wrong
This is an early-stage biospecimen collection study, not a treatment trial. It focuses on developing a research platform, so there is no direct benefit to participants and the device may never reach clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 DONORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 DONORS HEALTHY DONORS SOLID TUMOR, ADULT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

Locations

  • Carolina BioOncology Institute

    RECRUITING

    Huntersville, North Carolina, 28078, United States

    Contact Phone: •••-•••-••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.